Alternative 2: Fee Cost Recovery Fee $2,672 $2,730 $2,516 $2,369 $2,208 $12,495 $3,047 – Revenue Transfer Amount from Baseline for $74 $17 $68 $111 $71 $36 $303 Alternative 2 Alternative 3: Across the Board Adjustment $2,666 $2,796 $2,527 $2,414 $2,281 $12,684 $3,094 Fee Revenue – Transfer Amount $120 from Baseline for $11 $134 $122 $116 $109 $492 Alternative 3 Summary of the Final Rule Fee Schedule (Alternative 1) The Accounting Statement (as shown in Table 3-9) summarizes the qualitative costs and benefits as well as other impacts of the patent fee schedule set forth in the final rule. Overall, this Final Rule Fee Schedule (Alternative 1) has significant qualitative benefits to patent applicants, patent holders, other patent stakeholders, and society, with no identified qualitative costs. Table 39 Agency/Program Office: United States Patent and Trademark Office Rule Setting and Adjusting Patent Fees during Fiscal Year 2017 RIN#: 0651-AD02 Date: November 14, 2017 Primary Minimum Maximum Source Category Estimate Estimate Estimate Citation FY 2017 FY 2021 – BENEFITS (see section 4 for a detailed explanation of the benefits related to the baseline and alternatives)
Alternative 2: Fee Cost Recovery – Fee Revenue $2,672 $2,730 $2,516 $2,369 $2,208 $12,495 $3,047 Transfer Amount from Baseline for Alternative 2 $17 $68 $111 $71 $36 $303 $74 Alternative 3: Across the Board Adjustment – Fee Revenue $2,666 $2,796 $2,527 $2,414 $2,281 $12,684 $3,094 Transfer Amount from Baseline for Alternative 3 $11 $134 $122 $116 $109 $492 $120 Summary of the Final Rule Fee Schedule (Alternative 1) The Accounting Statement (as shown in Table 3-9) summarizes the qualitative costs and benefits as well as other impacts of the patent fee schedule set forth in the final rule. Overall, this Final Rule Fee Schedule (Alternative 1) has significant qualitative benefits to patent applicants, patent holders, other patent stakeholders, and society, with no identified qualitative costs. Table 39 Agency/Program Office: United States Patent and Trademark Office Rule Setting and Adjusting Patent Fees during Fiscal Year 2017 RIN#: 0651-AD02 Date: November 14, 2017 Category Primary Estimate Minimum Estimate Maximum Estimate Source Citation FY 2017 – FY 2021 BENEFITS (see section 4 for a detailed explanation of the benefits related to the baseline and alternatives)
Regulatory_Impact_Analysis.docx